A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR).
- 1 January 2001
- journal article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 18 (2), 146-150
- https://doi.org/10.1023/a:1011068015301
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Ligand-Dependent Regulation of Plasmid-Based Transgene Expression in VivoHuman Gene Therapy, 1999
- Activation by Diverse Xenochemicals of the 51-Base Pair Phenobarbital-Responsive Enhancer Module in theCYP2B10GenePublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1998
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Ecdysone-inducible gene expression in mammalian cells and transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Tetracycline-Controlled Gene Expression System Achieves High-Level and Quantitative Control of Gene ExpressionAnalytical Biochemistry, 1996
- The nuclear receptor superfamily: The second decadeCell, 1995
- Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis.Genes & Development, 1995
- A regulatory system for use in gene transfer.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.Proceedings of the National Academy of Sciences of the United States of America, 1992
- A novel mediator between activator proteins and the RNA polymerase II transcription apparatusCell, 1990